fluorodeoxyglucose f18 has been researched along with Cancer of Jaw in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Aigner, RM; Nazerani Hooshmand, T; Pau, M; Pernthaler, B; Szurian, K | 1 |
Chen, L; Li, F; Liu, Y; Niu, N | 1 |
Aoki, T; Kaneko, A; Karakida, K; Ota, Y; Otsuru, M; Tsukinoki, K; Yamazaki, H; Yasuda, M | 1 |
Gomes, H; Kalkani, M; Kalkanis, D; Paes, F; Sfakianakis, GN; Sideras, P | 1 |
Muzik, O; Peng, F; Rabkin, G | 1 |
Arai, K; Endo, K; Hanaoka, H; Higuchi, T; Iida, Y; Ishikita, T; Koyama, K; Miyakubo, M; Mogi, K; Nakasone, Y; Negishi, A; Oriuchi, N; Paudyal, B; Tsushima, Y | 1 |
Aigner, RM; Feichtinger, M; Kärcher, H | 1 |
7 other study(ies) available for fluorodeoxyglucose f18 and Cancer of Jaw
Article | Year |
---|---|
18F-FDG PET/CT in the Hyperparathyroidism-Jaw-Tumor Syndrome.
Topics: Adenoma; Adult; Female; Fibroma; Fluorodeoxyglucose F18; Humans; Hyperparathyroidism; Jaw Neoplasms; Positron Emission Tomography Computed Tomography | 2021 |
Multiple organ metastases from ameloblastoma detected by FDG PET/CT imaging.
Topics: Aged; Ameloblastoma; Fluorodeoxyglucose F18; Humans; Jaw Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Usefulness of 18F-fluorodeoxyglucose positron emission tomography for detecting ameloblastoma, with special reference to glucose transporter-1 expression.
Topics: Adult; Ameloblastoma; Biopsy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Humans; Jaw Neoplasms; Male; Mandibular Neoplasms; Maxillary Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Interesting image. FDG-PET/CT in primary large B-cell lymphoma of the hard palate.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Jaw Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Palate, Hard; Positron-Emission Tomography; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Use of 2-deoxy-2-[F-18]-fluoro-D-glucose positron emission tomography to monitor therapeutic response by rhabdomyosarcoma in children: report of a retrospective case study.
Topics: Child; Child, Preschool; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Jaw Neoplasms; Lung Neoplasms; Male; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Retrospective Studies; Rhabdomyosarcoma; Skull Neoplasms | 2006 |
Diagnosis of maxillofacial tumor with L-3-[18f]-fluoro-alpha-methyltyrosine (FMT) PET: a comparative study with FDG-PET.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Facial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Jaw Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tyrosine | 2007 |
F-18 positron emission tomography and computed tomography image-fusion for image-guided detection of local recurrence in patients with head and neck cancer using a 3-dimensional navigation system: a preliminary report.
Topics: Aged; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Jaw Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Surgery, Computer-Assisted; Tomography, X-Ray Computed; Tonsillar Neoplasms | 2008 |